IN VIVO INTERROGATION OF THE CONTRIBUTION OF SPECIFIC SPLICING FACTORS TO PATHOLOGICAL MIS-SPLICING IN HUNTINGTON´S DISEASE
Main Authors: | David Lozano-Muñoz, Ainara Elorza, María Santos-Galindo, José Lucas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266724212300917X |
Similar Items
-
Genetic therapies for RNA mis-splicing diseases
by: Hammond, S, et al.
Published: (2011) -
Genetic therapies for RNA mis-splicing diseases.
by: Hammond, S, et al.
Published: (2011) -
TAF1 SPLICING VARIANTS AND PROLYL HYDROXYLASE INHIBITORS IN HUNTINGTON’S DISEASE
by: Claudia Rodríguez-López, et al.
Published: (2023-10-01) -
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs
by: Huichun Tong, et al.
Published: (2023-10-01) -
Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts
by: Bashayer A. Khalifah, et al.
Published: (2023-11-01)